SCHEMBL30133793

SCHEMBL30133793

CCOC(=O)c1nn(C2CCCCO2)c(C)c1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
ALDH1A1 P00352 10/20 0.39
HPGD P15428 5/20 0.39
KDM4E B2RXH2 4/20 0.39
HSD17B10 Q99714 2/20 0.39
CSNK1D P48730 1/20 0.39
TSHR P16473 4/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ELANE P08246 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 2/20 0.37
TP53 P04637 2/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35
ATM Q13315 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20517501 0.85 MAPT (0.38) GAAALDH1A1HPGDHSD17B10CSNK1D
SCHEMBL16100241 0.85 ELANE (0.38) GAAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL16100242 0.85 ELANE (0.38) GAAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL31622731 0.85 ELANE (0.38) GAAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL30134356 0.81 MAPT (0.39) GAAALDH1A1HPGDTSHRELANE
SCHEMBL30133858 0.81 TSHR (0.40) ALDH1A1HPGDKDM4EHSD17B10TSHR
SCHEMBL30899996 0.81 RAB9A (0.37) GAAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL30133959 0.81 ELANE (0.38) ALDH1A1HPGDKDM4EHSD17B10CSNK1D
SCHEMBL23457143 0.79 ELANE (0.39) GAAALDH1A1HPGDKDM4EHSD17B10
SCHEMBL29576377 0.78 ELANE (0.41) ALDH1A1HPGDKDM4EHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 CN disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN disclosed
WO-2023011456-A1 PYRAZOLOPYRIDINONE COMPOUNDS BEIGENE, LTD. (KY) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300951-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK GAA 3007/4885ALDH1A1 1296/4885HPGD 1034/4885
US-20240270751-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK GAA 3007/4885ALDH1A1 1296/4885HPGD 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.